OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia
Arann Rowe, Louise Mercer, Valentina Casetti, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 2, pp. 197-211
Closed Access | Times Cited: 37
Arann Rowe, Louise Mercer, Valentina Casetti, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 2, pp. 197-211
Closed Access | Times Cited: 37
Showing 26-50 of 37 citing articles:
Pharmacological interventions in social cognition deficits: A systematic mapping review
Patricia Fernández-Sotos, Elena Navarro, Iosune Torío, et al.
Psychiatry Research (2018) Vol. 270, pp. 57-67
Closed Access | Times Cited: 17
Patricia Fernández-Sotos, Elena Navarro, Iosune Torío, et al.
Psychiatry Research (2018) Vol. 270, pp. 57-67
Closed Access | Times Cited: 17
Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia
Derek K. Tracy, Dan W. Joyce, Sagari Sarkar, et al.
BMC Psychiatry (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Derek K. Tracy, Dan W. Joyce, Sagari Sarkar, et al.
BMC Psychiatry (2015) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Schizophrenia: synthetic strategies and recent advances in drug design
Maria Azmanova, Anaïs Pitto‐Barry, Nicolas P. E. Barry
MedChemComm (2018) Vol. 9, Iss. 5, pp. 759-782
Open Access | Times Cited: 13
Maria Azmanova, Anaïs Pitto‐Barry, Nicolas P. E. Barry
MedChemComm (2018) Vol. 9, Iss. 5, pp. 759-782
Open Access | Times Cited: 13
Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: A pilot study
Robert Aidelbaum, Alain Labelle, Ashley Baddeley, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 5, pp. 541-551
Closed Access | Times Cited: 9
Robert Aidelbaum, Alain Labelle, Ashley Baddeley, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 5, pp. 541-551
Closed Access | Times Cited: 9
Substance Use Disorders and Schizophrenia
Marc W. Manseau, Michael P. Bogenschutz
FOCUS The Journal of Lifelong Learning in Psychiatry (2016) Vol. 14, Iss. 3, pp. 333-342
Open Access | Times Cited: 8
Marc W. Manseau, Michael P. Bogenschutz
FOCUS The Journal of Lifelong Learning in Psychiatry (2016) Vol. 14, Iss. 3, pp. 333-342
Open Access | Times Cited: 8
Association between lower estimated premorbid intelligence quotient and smoking behavior in patients with schizophrenia
Shinsuke Hidese, Junko Matsuo, Ikki Ishida, et al.
Schizophrenia Research Cognition (2018) Vol. 15, pp. 7-13
Open Access | Times Cited: 6
Shinsuke Hidese, Junko Matsuo, Ikki Ishida, et al.
Schizophrenia Research Cognition (2018) Vol. 15, pp. 7-13
Open Access | Times Cited: 6
Basal-Forebrain Cholinergic Nuclei Alterations are Associated With Medication and Cognitive Deficits Across the Schizophrenia Spectrum
Julia Schulz, Felix Brandl, Michel J. Grothe, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 6, pp. 1530-1541
Open Access | Times Cited: 2
Julia Schulz, Felix Brandl, Michel J. Grothe, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 6, pp. 1530-1541
Open Access | Times Cited: 2
What is the promise of nicotinergic compounds in schizophrenia treatment?
Juliane K. Mueller, Cathrin Rohleder, F. Markus Leweke
Future Medicinal Chemistry (2016) Vol. 8, Iss. 17, pp. 2009-2012
Closed Access | Times Cited: 3
Juliane K. Mueller, Cathrin Rohleder, F. Markus Leweke
Future Medicinal Chemistry (2016) Vol. 8, Iss. 17, pp. 2009-2012
Closed Access | Times Cited: 3
Integrative transcriptomics reveals sexually dimorphic microRNA control of the cholinergic/neurokine interface in schizophrenia and bipolar disorder
Sebastian Lobentanzer, Geula Hanin, Jochen Klein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 3
Sebastian Lobentanzer, Geula Hanin, Jochen Klein, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 3
The GSK3-NRF2 Axis in Suicide
Hans O. Kalkman
Psychiatry International (2021) Vol. 2, Iss. 1, pp. 108-119
Open Access | Times Cited: 2
Hans O. Kalkman
Psychiatry International (2021) Vol. 2, Iss. 1, pp. 108-119
Open Access | Times Cited: 2
Impact of the Alpha-7 Nicotinic Acetylcholine Receptor on Long-Term Potentiation within the Hippocampus: Implications in Schizophrenia
Candace M. Jones
Psychiatric Annals (2018) Vol. 48, Iss. 7, pp. 345-348
Closed Access
Candace M. Jones
Psychiatric Annals (2018) Vol. 48, Iss. 7, pp. 345-348
Closed Access
The effect of training intensity on implicit learning rates in schizophrenia
Natasza Orlov, Jessica Sanderson, Syed Ali Muqtadir, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access
Natasza Orlov, Jessica Sanderson, Syed Ali Muqtadir, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access
